11.80

1.26% -0.15

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $11.80, with a volume of 1.24M. It is down -1.26% in the last 24 hours and down -18.62% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$11.95

Open:

$11.95

24h Volume:

1.24M

Relative Volume:

2.45

Market Cap:

$690.45M

Revenue:

$1.10B

Net Income/Loss:

$83.60M

P/E Ratio:

8.2517

EPS:

1.43

Net Cash Flow:

$132.30M

1W Performance:

+0.94%

1M Performance:

-18.62%

6M Performance:

+17.53%

1Y Performance:

-40.04%

1-Day Range:

$11.46

$12.11

1-Week Range:

$11.02

$12.11

52-Week Range:

$9.20

$21.23

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1123)

Industry

Medical Instruments & Supplies (57)

Phone

(862) 401-0000

Address

1209 ORANGE STREET, WILMINGTON

Employee

1,850

Twitter

Next Earnings Date

2025-11-25

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	11.80	699.23M	1.10B	83.60M	132.30M	1.43
ISRG Intuitive Surgical Inc	542.32	194.04B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	200.89	57.21B	21.84B	1.68B	2.67B	5.8293
ALC Alcon Inc	78.80	38.69B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	252.27	36.84B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	267.56	19.61B	2.96B	487.70M	344.00M	6.6758

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Initiated	Mizuho	Neutral
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

Dec 12, 2025

Momentum Shift: How Applied Industrial Technologies Inc stock performs during Fed tightening cyclesMarket Volume Report & Consistent Income Trade Ideas - moha.gov.vn

Dec 12, 2025

Dec 07, 2025

Investors Holding Back On Embecta Corp. (NASDAQ:EMBC) - 富途牛牛

Dec 07, 2025

Dec 06, 2025

Aug Patterns: How Embecta Corp stock reacts to global recession fears2025 Market Overview & Verified Momentum Stock Alerts - moha.gov.vn

Dec 06, 2025

Dec 04, 2025

Why Embecta Corp. stock could rally in 2025Earnings Overview Summary & AI Forecast Swing Trade Picks - Newser

Dec 04, 2025

(EMBC) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Dec 04, 2025

Embecta To Go Ex-Dividend On December 5th, 2025 With 0.15 USD Dividend Per Share - 富途牛牛

Dec 04, 2025

Dec 03, 2025